Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.
About
EyePoint Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products for patients with serious eye disorders. Their proprietary Durasert® technology enables sustained intraocular drug delivery, aiming to reduce the frequency of treatments and improve patient outcomes.
Tags
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does EyePoint Pharmaceuticals do?
EyePoint Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products for patients with serious eye disorders. Their proprietary Durasert® technology enables sustained intraocular drug delivery, aiming to reduce the frequency of treatments and improve patient outcomes.
How much funding has EyePoint Pharmaceuticals raised?
EyePoint Pharmaceuticals has raised a total of $436M in funding. The most recent round on record is Public Offering.
Where is EyePoint Pharmaceuticals headquartered?
EyePoint Pharmaceuticals is headquartered in Watertown, United States.
When was EyePoint Pharmaceuticals founded?
EyePoint Pharmaceuticals was founded in 1987.
What industry does EyePoint Pharmaceuticals operate in?
EyePoint Pharmaceuticals operates in Biotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology, Drug Delivery Systems, Medical Devices.
Similar Startups